- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00716599
Training in Fever Case Management With Rapid Diagnostic Tests (RDTs) for Malaria in Uganda
Effectiveness and Safety of Training in Fever Case Management Incorporating Rapid Diagnostic Tests (RDTs) for Malaria at Peripheral Health Centers in Uganda
Malaria remains one of the most devastating infectious diseases in the world. Despite the potential for serious adverse outcomes with each episode of malaria, most cases in endemic areas are diagnosed on clinical grounds alone. Even the simple technique of light microscopy, the gold standard for malaria diagnosis, is inaccessible to most individuals in resource-poor malarious areas. New diagnostic methods that are practical for limited health-care settings are urgently needed. Immunochromatographic rapid diagnostic tests (RDTs) for malaria are easy to use, require little infrastructure or expertise, show good accuracy, and are increasingly advocated for routine use in malaria-endemic areas. A major challenge now is to implement RDTs effectively in typical African clinical settings. We plan to evaluate the clinical effectiveness and safety of a training curriculum incorporating RDT use in peripheral government health centers in Uganda. Results from this study will provide evidence for scale-up of RDT implementation in Uganda, as planned by the Uganda Ministry of Health from mid-2008, as well as in other sub-Saharan African countries.
The aim of this study is to evaluate the clinical effectiveness and safety of a basic training program incorporating RDTs, as compared with standard-of-care presumptive treatment, for the management of patients who present with suspected malaria at peripheral health centers in Uganda. Our hypothesis is that training in fever case management and RDT use will allow health center staff to reduce unnecessary antimalarial prescriptions without compromising patient outcomes, compared with the current practice of presumptive antimalarial therapy for all febrile patients.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kampala, Uganda
- Uganda Malaria Surveillance Project
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- all outpatients at participating health centers
Exclusion Criteria:
- patient refusal
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Health centers continue with standard-of-care empiric case management
|
|
Experimental: RDT training
Health centers randomly selected to receive training and RDTs, for use in routine patient case management
|
training program and introduction of RDTs for use in case management of patients presenting for routine care at government health centers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To compare changes in the proportion of patients prescribed any antimalarial therapy between health centers with and without an RDT training intervention.
Time Frame: point of care
|
point of care
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To compare changes in the proportion of patients with an inadequate response to initial therapy between health centers with and without an RDT training intervention.
Time Frame: 5 days after initial clinic visit
|
5 days after initial clinic visit
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Heidi Hopkins, MD, University of California, San Francisco
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EM-036
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fever
-
Meir Medical CenterCompleted
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedYellow Fever | Dengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
U.S. Army Medical Research and Development CommandBausch Health Americas, Inc.WithdrawnCrimean-Congo Hemorrhagic Fever | Lassa FeverGermany
-
The Scientific and Technological Research Council...MonitorCROCompleted
-
Sanofi Pasteur, a Sanofi CompanyUnited States Department of DefenseCompletedDengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
Tongji HospitalRecruitingHFRS (Hemorrhagic Fever With Renal Syndrome)China
-
Shaare Zedek Medical CenterCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedDengue Fever | Dengue Hemorrhagic FeverSingapore
-
Carina Mari ApariciWithdrawnFever of Unknown OriginUnited States
Clinical Trials on training in use of rapid diagnostic tests (RDTs) for malaria
-
Fujirebio Diagnostics, Inc.CompletedHeart FailureUnited States
-
De Soysa Hospital for WomenClinical Innovations, LLCUnknownPremature Rupture of MembranesSri Lanka
-
University of NottinghamUniversity of BeninUnknown
-
Clinical Innovations, LLCUnknown
-
The Immunobiological Technology Institute (Bio-Manguinhos)...Conselho Nacional de Desenvolvimento Científico e TecnológicoUnknownHuman Immunodeficiency Virus | Human Immunodeficiency Virus Transmission | Diagnoses, Syndromes, and ConditionsBrazil
-
Hospices Civils de LyonRecruitingNeurocognitive DisordersFrance
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitation
-
HIV Prevention Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID); Division of...Enrolling by invitationHIV Infection | Sexually Transmitted Infections | Pre-exposure Prophylaxis | Systems NavigationMalawi